Literature DB >> 11097361

Differential expression of MUC2 and MUC5AC in benign and malignant glandular lesions of the cervix uteri.

L Riethdorf1, J T O'Connell, S Riethdorf, A Cviko, C P Crum.   

Abstract

The expression of mucin genes in the normal glandular epithelium of the endocervix has been well characterized. However, mucin gene expression in neoplastic or particular non-neoplastic glandular cervical lesions has not been addressed. This immunohistochemical study was carried out to analyze the expression of MUC2 and MUC5AC in neoplastic and non-neoplastic glandular lesions of the cervix. Monoclonal antibodies were used on paraffin-embedded sections from 41 adenocarcinomas, 2 adenosquamous carcinomas, 13 adenocarcinomas in situ (ACIS), 3 glandular dysplasias, 8 endometrioses, 5 tubal metaplasias, 17 squamous metaplasias, 3 microglandular hyperplasias and normal tissue of the endocervix, endometrium and fallopian tube. The patterns of expression of MUC2 and MUC5AC were different and in principle contrary. Focal MUC2 expression was observed almost exclusively in neoplastic lesions (36%) and not in normal epithelia and non-neoplastic lesions, the one notable exception being immature metaplasia. In contrast, strong expression of MUC5AC was observed in both normal endocervical epithelium (100%) and neoplastic lesions (73%). The expression of MUC5AC, however, was diminished in most neoplastic glandular lesions. Co-expression of MUC2 and MUC5AC was consistently documented in the lesions with intestinal differentiation. In contrast, cases of tubal metaplasia and endometriosis were negative for MUC2 and MUC5AC. These results indicate that discrimination of mucin gene expression may be helpful in discriminating lesions of the cervix.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11097361     DOI: 10.1007/s004280000273

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  12 in total

Review 1.  [Diagnosis and differential diagnosis of cervical adenocarcinoma].

Authors:  T Löning; L Riethdorf; M Köbel
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

Review 2.  Differentiating rectal carcinoma by an immunohistological analysis of carcinomas of pelvic organs based on the NCBI Literature Survey and the Human Protein Atlas database.

Authors:  Koh Miura; Kazuyuki Ishida; Wataru Fujibuchi; Akihiro Ito; Hitoshi Niikura; Hitoshi Ogawa; Iwao Sasaki
Journal:  Surg Today       Date:  2012-03-23       Impact factor: 2.549

3.  Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinoma.

Authors:  Sebastian Dwertmann Rico; Franziska Büscheck; David Dum; Andreas M Luebke; Martina Kluth; Claudia Hube-Magg; Andrea Hinsch; Doris Höflmayer; Daniel Perez; Jakob R Izbicki; Michael Neipp; Hamid Mofid; Thies Daniels; Christoph Isbert; Christoph Fraune; Katharina Möller; Anne Menz; Christian Bernreuther; Patrick Lebok; Till Clauditz; Guido Sauter; Ria Uhlig; Waldemar Wilczak; Ronald Simon; Stefan Steurer; Eike Burandt; Andreas Marx; Till Krech
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.298

4.  p16INK4A positivity in benign, premalignant and malignant cervical glandular lesions: a potential diagnostic problem.

Authors:  N Murphy; C C B B Heffron; B King; U G Ganuguapati; M Ring; E McGuinness; O Sheils; J J O'Leary
Journal:  Virchows Arch       Date:  2004-09-18       Impact factor: 4.064

Review 5.  Ramifications of secreted mucin MUC5AC in malignant journey: a holistic view.

Authors:  Shiv Ram Krishn; Koelina Ganguly; Sukhwinder Kaur; Surinder K Batra
Journal:  Carcinogenesis       Date:  2018-05-03       Impact factor: 4.944

6.  MUC2 polymorphisms are associated with endometriosis development and infertility: a case-control study.

Authors:  Cherry Yin-Yi Chang; Yi Chen; Wu-Chou Lin; Chih-Mei Chen; Chih-Ping Chen; Shan-Chih Lee; Jim Jinn-Chyuan Sheu; Fuu-Jen Tsai
Journal:  BMC Med Genet       Date:  2012-03-15       Impact factor: 2.103

7.  Elevated MUC5AC expression is associated with mismatch repair deficiency and proximal tumor location but not with cancer progression in colon cancer.

Authors:  Sebastian Dwertmann Rico; Doris Höflmayer; Franziska Büscheck; David Dum; Andreas M Luebke; Martina Kluth; Claudia Hube-Magg; Andrea Hinsch; Christina Möller-Koop; Daniel Perez; Jakob R Izbicki; Michael Neipp; Hamid Mofid; Hannes Lárusson; Thies Daniels; Christoph Isbert; Stephan Coerper; Daniel Ditterich; Holger Rupprecht; Albert Goetz; Christoph Fraune; Katharina Möller; Anne Menz; Christian Bernreuther; Till S Clauditz; Guido Sauter; Ria Uhlig; Waldemar Wilczak; Ronald Simon; Stefan Steurer; Patrick Lebok; Eike Burandt; Till Krech; Andreas H Marx
Journal:  Med Mol Morphol       Date:  2020-12-29       Impact factor: 2.309

8.  Alterations in mucin expression in ovarian mucinous tumors: immunohistochemical analysis of MUC2, MUC5AC, MUC6, and CD10 expression.

Authors:  Kenichi Hirabayashi; Masanori Yasuda; Hiroshi Kajiwara; Johbu Itoh; Masaki Miyazawa; Takeshi Hirasawa; Toshinari Muramatsu; Masaru Murakami; Mikio Mikami; Robert Yoshiyuki Osamura
Journal:  Acta Histochem Cytochem       Date:  2008-04-26       Impact factor: 1.938

9.  Colloid Carcinoma of the Uterine Cervix and Its Immunohistochemical Analysis: A Case Report.

Authors:  Nermin Koc; Sevcan Arzu Arinkan; Nurver Ozel Ozbay; Selcuk Selcuk
Journal:  J Pathol Transl Med       Date:  2018-01-15

10.  A combination of cytokeratin 5/6, p63, p40 and MUC5AC are useful for distinguishing squamous cell carcinoma from adenocarcinoma of the cervix.

Authors:  Hailing Li; Xiaotong Jing; Jie Yu; Jiannan Liu; Tingguo Zhang; Shiming Chen; Xiaofang Zhang
Journal:  Diagn Pathol       Date:  2020-08-26       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.